• News
  • Finance

Ligand's 1Q revenues increase 37% from 2013

Ligand Pharmaceuticals Inc. (Nasdaq: LGND) Wednesday reported total revenues for the first quarter of 2014 increased 37 percent to $16 million, compared with the first quarter of 2013.

The company's royalty revenues increased 35 percent to $7.9 million, and its non-GAAP net income from continuing operations was $0.35 per diluted share.

Ligand also reported its net income increased 40 percent in the first three months ended March 31, 2014, from the same period a year ago to $2.1 million, or $0.10 per diluted share.

User Response
0 UserComments